The latest from DTC Perspectives

Study Finds DTC Harmful to the American Public, Offers Recommendations

Tuesday, 24 November 2009, 03:09 PM

A recent study in the American Journal of Public Health weighs the opinions for and against DTC and uses these differing opinions to proffer several guidelines to aid in the beneficial nature of DTC towards the American public and minimize the risks of that form of communication.

The study argues that while “ [DTC] advertising has some benefits…significant risks are evident as well, magnified by the prominence of DTCA in population-level health communications.”  In other words, DTC is targeted towards every American consumer, putting those that do not understand the nature of DTC advertisements at risk for mis-communication. 

The researchers believe “DTCA amounts to a large and expensive uncontrolled experiment in population health, which to date shows decidedly mixed effects.”  With implementation of their guidelines, the researches feel that DTC can lessen its burden on public health.

The authors reveal 3 primary recommendations for DTC marketing in their study:

1.   “Ads should facilitate the identification of appropriate patient candidates for treatment.”  The researchers feel that DTC campaigns do not appropriately express to whom their message is specifically targeted.  They believe identifying the target market of a DTC campaign “could reduce inappropriate prescribing.”

2.   “Ads should provide for all products: accurate and specific information about the potential benefits of advertised drugs instead of the current qualitative and emotion-driven portrayals that often suggest misleadingly dramatic effects.”  The researchers cite clinical trials in which quantitative benefit data was included in DTC and led to “more realistic consumer appraisals of effectiveness.”

3.   “Ads should provide specific quantitative information about the potential risks associated with drugs.” The researchers note a disconnect between the visual imagery and auditory messaging in many DTC messages causing an “inadequate processing of verbal risk information.”

It is interesting that the study’s third recommendation is heavily in line with a guideline underlined in the DDMAC draft guidance distributed last May. 

Related articles

New Harvard Study Reveals DTC Increases Drug Cost to Medicaid

The study, examining the drug clopidogrel’s (Plavix) expenditure and sales before and after its use of DTC reveals that Medicaid expenditures increased while the

New EVP, Managing Director for Saatchi

Saatchi & Saatchi Wellness has named Ned Russell as executive vice president, managing director. He succeeds Jim Joseph, who left the agency to become a partner and

Committee Leaders Request GAO Report on Rx Pricing Trends

Rep. Charles Rangel (D-N.Y.), chairman of the House Ways and Means Committee, and Rep. Henry Waxman (D-Calif.), chairman of the Energy and Commerce Committee, teamed

Newcomer Pristiq Ranks Among Nielsen's Most Recalled DTC Spots

While four of the top five DTC television spots in the ranking of “Most Recalled Prescription Drug Ads of 2008-2009” from Nielsen IAG are holdovers from last year,

The FDA Internet Dilemma

The 2 day hearings held last week aired all the issues related to drug marketing over the Internet. It is ridiculous that the FDA is using a promotional code written

Read all related articles

DTC and You

The DTC National Conference

Register Now for The DTC National Conference 
April 7-9, 2010, Washington DC. The Formum for DTC 
Thought Leaders

 FREE Subscription to our Magazine
Start a free subscription now to the industry's leading
publication focused soley on DTC marketing,
 DTC Perspectives Magazine is published quarterly.

Subscribe to DTC Insights

The DTC Marketer's Executive Brief - DTC INSIGHTS
takes all the information and data pertinent to DTC
and analyzes it for a busy pharma marketer.

Subscribe to Bob Ehrlich’s newsletter

A weekly blog column from DTCPI CEO Bob Ehrlich
that reflects his observations on key trends affecting
our industry.

     Visit us on Facebook
DTC Perspectives, Inc is now on Facebook. Stay
Informed on the latest trends in the industry.


ABOUT SSL CERTIFICATES